Scientific Statements on Brain Cytoprotection in Ischemic Stroke—A Scientific Statement from the Chinese Stroke Association
Ischemic stroke is one of the serious diseases that cause death and disability.One of the important reasons for the unsatisfactory prognosis of patients with ischemic stroke is the damage to brain tissue resulting from the ischemic cascade reaction.Therefore,active brain cytoprotection therapy is essential for ischemic stroke treatment.In recent years,evidence from many preclinical studies and clinical research has emerged at home and abroad.With the emergence of new therapeutic targets and breakthroughs in treatment approaches,combined with the content of the latest Stroke Treatment Academic Industry Roundtable,this paper makes a scientific statement on the exploration of strategies to bridge the gap of clinical transformation in ischemic stroke,clinical research on brain cytoprotection,and how can exploration contribute to the clinical transformation of more treatment approaches.The objective is to promote the development of preclinical studies and clinical research in brain cytoprotection for ischemic stroke,and further improve the clinical prognosis of patients with ischemic stroke.
国家科技期刊平台
NSTL
万方数据
